Zhong Nanshan praises Chuangxin Pingshan! This conference is too "material"!
Author:Lin Yiying, Zhao LuDate:2021-03-10From:Pingshan District Science and Technology Innovation Bureau, Pingshan Financial Media Center


Qu Fenghong, deputy secretary-general of the National Committee of the Chinese People's Political Consultative Conference, full-time vice chairman and secretary-general of the Central Committee of the Peasants and Workers Party, Bian Zhenjia, special researcher of the Counselor's Office of the State Council, and leader of the National New Drug Innovation and Supervision and Evaluation Team of the Ministry of Science and Technology, deputy director of the Standing Committee of Shenzhen Municipal People’s Congress Jiang Yuyang, Chairman of the Municipal Association for Science and Technology, Gu Xiaohong, Secretary of the Party Committee of Beijing University of Traditional Chinese Medicine, Sun Yanrong, Deputy Director of China Biotechnology Development Center, Zhou Siyuan, Deputy Director of the Drug Evaluation Center of the National Medical Products Administration, and Tao Yongxin, Secretary of the Pingshan District Committee attended the opening ceremony. More than 100 academicians, scientists, experts and scholars in the medical field, as well as high-level and technical elites from Fortune 500 companies, innovative research project teams, and venture capital investment institutions, attended the conference, and nearly 10,000 participated in the conference.

2020深圳国际生物健康产业展览会-1.png 2020深圳国际生物健康产业展览会-2.png

2020深圳国际生物健康产业展览会-3.png 2020深圳国际生物健康产业展览会-4.png

Before the opening ceremony, Academician Zhong Nanshan, winner of the "Medal of the Republic", delivered a speech for the conference via video. He said that Shenzhen is an innovative city as well as a promising city. Pingshan is currently planning a new medical science academy and a new innovation and entrepreneurial talent system reform in the biomedical industry. This is an important measure to promote the accelerated application and penetration of technologies and talents in the biomedical field to the environment, resources, and health.


At the meeting, experts, scholars and industry leaders aimed to promote the innovation and development of the biomedical industry in the Guangdong-Hong Kong-Macao Greater Bay Area, and conducted in-depth discussions on building an internationally influential biomedical industry innovation pilot zone in the Guangdong-Hong Kong-Macao Greater Bay Area. It provides development ideas and paths for Shenzhen and Pingshan District to deeply grasp the global biomedical industry development trend and build a world-class biomedical technology industry city.


Qu Fenghong said that the Chinese Peasants and Workers Democratic Party is willing to rely on the human resources in the medical and health field, give full play to the advantages of the contact sector, strengthen the horizontal connection with the biomedical industry, and work together with Shenzhen to build a globally competitive biomedical industry highland. At the same time, I also hope that industry elites will actively contribute to the development of the biomedical industry in Shenzhen and even the whole country, and participate more in the construction of the pilot demonstration zone of socialism with Chinese characteristics, and share the dividends of reform and development.


Bian Zhenjia said that I hope that the country's new drug research and development workers will increase the innovation of new drugs, especially the original innovation, under the current international and domestic dual-cycle background. I also hope that Pingshan District, Shenzhen, can become a demonstration zone in the country in terms of biomedicine and make greater contributions to my country's medical industry.


Jiang Yuyang expressed the hope that Pingshan will seize the major historical opportunity of “dual drive” in the construction of the Guangdong-Hong Kong-Macao Greater Bay Area and Shenzhen Pilot Demonstration Zone from a new starting point, take the lead in the biopharmaceutical industry and take the lead in exploring innovative paths for industrial development. Shenzhen's biopharmaceutical industry contributes more to the high-quality development.


During the conference, Tao Yongxin said,

Pingshan is one of Shenzhen's youngest administrative districts with the most potential for development. With a high concentration of industries and active innovation and entrepreneurship, Pingshan has been assigned the development positioning of the eastern center of Shenzhen, the core park of the Shenzhen National High-tech Zone and the Shenzhen Future Industrial Pilot Zone by the municipal party committee and municipal government. In 2005, Pingshan was awarded the first batch of national bio-industry bases by the National Development and Reform Commission. At the beginning of this year, the municipal party committee and the municipal government issued a "1+3" policy document for the agglomeration and development of the biopharmaceutical industry, clearly establishing Pingshan as the development pattern of Shenzhen biomedicine "one core and multiple centers" Core area. Currently, there are 615 biomedical companies in the district, with an average annual growth rate of more than 30%. During the epidemic, the output value increased by nearly 40% against the trend. The biomedical industry is moving towards high-end and internationalization.


This year marks the 40th anniversary of the establishment of the Shenzhen Special Economic Zone. General Secretary Xi Jinping personally attended the celebration meeting and delivered an important speech, placing high hopes on Shenzhen's reform, opening up, and innovative development. The Party Central Committee has specifically issued support for Shenzhen’s construction of a pioneering demonstration zone of socialism with Chinese characteristics and comprehensive reform pilot implementation plans, allowing Shenzhen to use the legislative power of the special zone in biomedicine and other fields to explore pilot policies, which has brought significant development to Shenzhen’s biomedical industry. Historical opportunity. Pingshan will make full use of the comprehensive reform pilot policy dividends in accordance with the deployment requirements of the Municipal Party Committee and the Municipal Government, and give full play to its strong policy support, close cooperation in the Bay Area, complete technology and financial system, complete scientific research platform carriers, low innovation costs, and first-class business environment With such advantages, we will work with innovative and entrepreneurial talents at home and abroad to jointly draw a "Pingshan Blueprint" for the development of biomedicine, and help Shenzhen to accelerate the development of the core engine of the biomedical industry in the Guangdong-Hong Kong-Macao Greater Bay Area.


"1+1+1+10" big coffee gathered

Accelerate the construction of a global innovation ecosystem


The conference specifications are improved, the format is novel, and the guest lineup is unprecedentedly strong. Behind this grand event of the biopharmaceutical industry, what is reflected is the steaming and thriving development atmosphere of Pingshan, which is a manifestation of the agglomeration and development of Pingshan biomedical industry and the continuous improvement of the "magnetic effect". It is even more that Pingshan is seizing opportunities and striving An initiative to promote.


Sun Yongkui, Academician of the American Academy of Engineering, serves as the chairman of the conference; Zhang Mingjie, Academician of the Chinese Academy of Sciences, Founding Fellow of the Hong Kong Academy of Sciences, and Dean of the School of Life Sciences of SUSTech; Dean of Zhejiang University Institute of Life Sciences, Special Assistant to the President, Member of the Academic Committee of the University, and Professor Feng Xinhua, American AAAS Fellow ; Executive Vice Dean of the School of Life Sciences, Beijing University of Chinese Medicine, Professor Shi Yuanyuan, Executive Dean of the Research Institute of Beijing University of Chinese Medicine in Shenzhen, etc. Deans of the three major schools of life sciences gave speeches on the same stage; Junshi Bio, BeiGene, WuXi AppTec, etc. A large number of founders and leaders of well-known companies attended the venue to give keynote speeches or participate in forum discussions.


This conference was held in the form of "1+1+1+10" through offline and online integration (1 closed-door meeting & industry leader summit, 1 main forum, 10 sub-forums), which attracted national biomedicine More than 130 industry leaders and guests were present. They put forward many valuable insights on how to accurately lay out the cutting-edge, key technology and important elements of biomedicine in Shenzhen and Pingshan. At the same time, they also provided directional guidance for the innovative development of China's biomedical industry.


"The gathering of so many heavyweight guests is not only because Pingshan has an excellent industrial chain of biomedicine, but also because Pingshan has created a global innovation ecosystem that has provided sufficient momentum for the development of the industry and has formed a unique advantage. "Some experts at the conference said.


In fact, this conference and exhibition are held in high standards

It is also Pingshan actively promoting the innovation chain

Integrated development of industrial chain, talent chain, and education chain

Accelerate the construction of a microcosm of the global innovation ecosystem

Set up a platform to lead the way, recruit the strong and attract the best

Benchmark first-class standards to improve development elements

Pingshan’s innovative advantages are becoming more apparent


A 3.6-kilometer-long Jinxiu East Road gathers 191 biopharmaceutical companies and 11 listed companies, forming an eye-catching "BT Avenue", which is the best testimony to the high-quality gathering and vigorous development of the Pingshan biopharmaceutical industry . In recent years, Pingshan District has added more than 100 biopharmaceutical companies annually, and its industrial output value has increased by more than 30% annually. As of the third quarter, the number of biomedical companies in the district has reached 615, forming a good trend of "Pingshan preferred by biomedical companies".


Pingshan District has also successively introduced Shenzhen Bay Laboratory Pingshan Biomedicine R&D and Transformation Center, Monash Technology Transformation Research Institute, Southern University of Science and Technology Pingshan Biomedical Research Institute, Shenzhen University of Technology School of Pharmacy, Shenzhen Beijing University of Chinese Medicine Research Institute, etc. First-class technological innovation and achievement transformation platform. At the same time, new institutions such as the Academy of Medical Sciences and the Hong Kong Famous Medical Clinic have also settled in Pingshan.


Formulate the "Longju Pingshan" talent policy, improve the housing guarantee for talents, and introduce methods for contacting and serving talents... Statistics show that on average, Pingshan settles in more than 100 overseas teams every year. At present, there are more than 700 doctors in the jurisdiction, of which returnees account for nearly 50%. , An increase of about 5 times compared with 2016.



With the continuous integration of innovative elements

A "core cluster area" of the city's biomedical industry

Will rise in Pingshan


10 projects are collectively signed
Speed up the construction of a batch of major projects

At the opening ceremony of the day, Pingshan District signed contracts for strategic cooperation with Dapeng New District and Shenzhen Third People’s Hospital. At the same time, Shenzhen Beijing University of Traditional Chinese Medicine Research Institute, Southern University of Science and Technology Pingshan Biomedical Research Institute, The opening ceremony of the South China Security Evaluation Center of the Shanghai Institute of Materia Medica of the Chinese Academy of Sciences and the Anling Biomedical (Shenzhen) Co., Ltd., etc., the opening ceremony of the Hong Kong famous doctor's diagnosis and treatment center, the launching ceremony of the ICH Park construction, and the opening ceremony of the Freehand Bay Area Club.


It is noteworthy that

The ICH park started this time

Pingshan explores and builds to be in line with international rules

Biomedical Industry Cluster Park

The park will form an innovative industrial chain of "basic research + technology development + achievement transformation + financial support", establish a park operating organization that meets international standards, and engage in investment promotion, product development, OEM production, skills training, investment and financing, and patent declaration. , Achievement transformation and other aspects to provide full service for enterprises in the park.


It is foreseeable that

With the continuous extension of the depth and breadth of cooperation

And the BE/I phase clinical trial center of Sami Hospital, etc.

Speeding up the construction of a batch of major projects

Pingshan Biomedical Industry Development

Will inject stronger kinetic energy


In addition, Pingshan will actively seize the "dual zone drive"

And a major historical opportunity for comprehensive authorization reform pilots

Strive to continue to explore breakthroughs in policy first, first trial and other aspects

Further enhance the advantages of the biomedical industry


In order to appropriately play the leading role of the policy on the industry, Pingshan will actively strive for the decentralization of related review and certification authority for drugs and medical devices; strive for the construction of the Pingshan base of the Guangdong-Hong Kong-Macao Greater Bay Area Center of the National Medical Products Administration; strive for the construction of the Pingshan Base of the Guangdong-Hong Kong-Macao Greater Bay Area Center of the National Medical Products Administration; Relevant comprehensive authorization reform pilots, simplify the approval process for drugs and devices that have been marketed abroad; open a green channel for import and export customs clearance of items used in biomedical research and development activities, and promote the cross-border flow of scientific research personnel, funds, biological products, reagents, etc., and rapid customs clearance Wait.


Next, Pingshan will also integrate the entire industrial chain of integrated innovation R&D-results transformation-manufacturing, relying on the policy advantages of the Guangdong-Hong Kong-Macao Greater Bay Area, and make good use of the institutional diversity and complementarity of the “one country, two systems and three tariff areas” to carry out institutional innovation. Strengthen cooperation on introduction, capital flow, industry-university-research cooperation, trade clearance, and the introduction of foreign capital to create a biomedical industry ecosystem with Pingshan characteristics and the core engine of the biomedical industry in the Guangdong-Hong Kong-Macao Greater Bay Area.

Back to top